EGFR and lung adenocarcinoma: For instance, in EGFR-mutant lung adenocarcinoma, quantitative assessment of EGFR-pTyr1197 phosphorylation via targeted MS of liquid biopsy samples or immunohistochemistry on serial tumor biopsies provides a direct pharmacodynamic readout.